Mestranol

Mestranol is a synthetic steroidal estrogen, recognized as the 3-methyl ether derivative of ethinylestradiol. Historically significant, mestranol was a key component in many of the inaugural oral contraceptive formulations.
Overview[edit]
Mestranol functions as a prodrug, which means it undergoes metabolic conversion in the body to produce the active form of estrogen, ethinylestradiol. This conversion occurs primarily in the liver and has an efficiency of approximately 70%. Pharmacokinetically, 50 µg of mestranol is roughly equivalent to 35 µg of ethinylestradiol in terms of biological activity.
Synthesis[edit]

The synthesis of mestranol exemplifies the unique stereospecificity inherent in certain steroid reactions. The 17-keto steroids, when subjected to nucleophilic reactions, predominantly undergo reactions on the alpha face. This is because the beta face is largely shielded by the 18-methyl group, making it almost inaccessible to reactants. The result of this bias is the predominant formation of isomers resulting from alpha face attacks.
Historical Context[edit]
The inclusion of mestranol in the first generation of oral contraceptives marked a significant advancement in reproductive health. Its efficacy as an estrogen component helped establish the viability of hormonal contraceptives as a method for pregnancy prevention.
Pharmacology[edit]
Upon administration, mestranol undergoes demethylation in the liver to produce ethinylestradiol, the active estrogenic component. This metabolic pathway accounts for mestranol's role as a prodrug.
Clinical Implications[edit]
Given its bioequivalence to ethinylestradiol, mestranol's dosage in oral contraceptives was adjusted to ensure the desired therapeutic effects while minimizing potential side effects. Over time, as advancements in pharmaceuticals were made, newer forms of oral contraceptives replaced those containing mestranol, though its historical significance remains.
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
